Atlas Trials

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

Clinical trial NCT01154140 · COMPLETED

Trial details

NCT number
NCT01154140
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non Squamous Lung Cancer
Start date
2011-01-13
Primary completion
2013-11-30
Enrollment
343

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.